RGAHX | USLYX | RGAHX / USLYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 34.146 | 22.164 | 154% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 313B | 2.39B | 13,118% |
Annual Yield % from dividends | 0.64 | 0.00 | - |
Returns for 1 year | 35.52 | 23.14 | 153% |
Returns for 3 years | 18.86 | 13.13 | 144% |
Returns for 5 years | 56.03 | 49.24 | 114% |
Returns for 10 years | N/A | 93.01 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TGWTX | 17.42 | -0.02 | -0.11% |
Transamerica Large Growth I3 | |||
SBHIX | 23.14 | -0.13 | -0.56% |
Saratoga Health & Biotechnology I | |||
NIEYX | 14.42 | -0.09 | -0.62% |
BNY Mellon International Equity Y | |||
KLCCX | 11.01 | -0.07 | -0.63% |
Federated Hermes Kaufmann Large Cap C | |||
MKVCX | 13.12 | -0.65 | -4.71% |
MFS International Large Cap Value C |